Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy Life Science Investing
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Life Science Investing
Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 Life Science Investing
C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 Life Science Investing
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 Life Science Investing
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis Life Science Investing
Rakovina Therapeutics Reports Strong Industry Validation and Emerging Collaborations Following 9th Annual DDR Inhibitors Summit Life Science Investing
MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia Life Science Investing
Marvel Biosciences Receives Japanese Patent Covering Composition of Matter for Its Lead Therapeutic Candidate MB-204 Life Science Investing